Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid… - American Journal of …, 2017 - Am Psychiatric Assoc
Objective: Research and clinical translation in schizophrenia is limited by inconsistent
definitions of treatment resistance and response. To address this issue, the authors …
definitions of treatment resistance and response. To address this issue, the authors …
Clozapine v. first-and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
D Siskind, L McCartney, R Goldschlager… - The British Journal of …, 2016 - cambridge.org
BackgroundAlthough clozapine is the 'gold standard'for treatment-refractory schizophrenia,
meta-analyses of clozapine for this condition are lacking. AimsWe conducted a systematic …
meta-analyses of clozapine for this condition are lacking. AimsWe conducted a systematic …
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements
RW Buchanan, J Kreyenbuhl, DL Kelly… - Schizophrenia …, 2010 - academic.oup.com
In light of the large number of studies published since the 2004 update of Schizophrenia
Patient Outcomes Research Team psychopharmacological treatment recommendations, we …
Patient Outcomes Research Team psychopharmacological treatment recommendations, we …
Almost all antipsychotics result in weight gain: a meta-analysis
M Bak, A Fransen, J Janssen, J van Os, M Drukker - PloS one, 2014 - journals.plos.org
Introduction Antipsychotics (AP) induce weight gain. However, reviews and meta-analyses
generally are restricted to second generation antipsychotics (SGA) and do not stratify for …
generally are restricted to second generation antipsychotics (SGA) and do not stratify for …
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of …
These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in …
Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in …
Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis
Clozapine is the most effective antipsychotic for the 25% to 33% of people with
schizophrenia who are treatment resistant, but not all people achieve response. Using data …
schizophrenia who are treatment resistant, but not all people achieve response. Using data …
Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis
MT Samara, M Dold, M Gianatsi… - JAMA …, 2016 - jamanetwork.com
Importance In treatment-resistant schizophrenia, clozapine is considered the standard
treatment. However, clozapine use has restrictions owing to its many adverse effects …
treatment. However, clozapine use has restrictions owing to its many adverse effects …
[BOOK][B] The Maudsley prescribing guidelines
D Taylor, C Paton - 2009 - taylorfrancis.com
One of the most widely used guides to prescribing psychiatric medications, the Tenth Edition
of Maudsley Prescribing Guidelines returns with fully updated content and new sections on …
of Maudsley Prescribing Guidelines returns with fully updated content and new sections on …
Clozapine versus typical neuroleptic medication for schizophrenia
A Essali, NAH Haasan, C Li… - Cochrane database of …, 2009 - cochranelibrary.com
Background Long‐term drug treatment of schizophrenia with typical antipsychotic drugs has
limitations: 25 to 33% of sufferers have illnesses that are treatment resistant. Clozapine is an …
limitations: 25 to 33% of sufferers have illnesses that are treatment resistant. Clozapine is an …
Clozapine versus other atypical antipsychotics for schizophrenia
CA Lobos, K Komossa… - Cochrane Database …, 2010 - cochranelibrary.com
Background Clozapine is an atypical antipsychotic demonstrated to be superior in the
treatment of refractory schizophrenia which causes fewer movement disorders. Clozapine …
treatment of refractory schizophrenia which causes fewer movement disorders. Clozapine …